全球心臟帮浦设备市场规模、份额、趋势和成长分析报告（2026-2034年）

预计心臟辅助设备市场将从 2025 年的 47.4 亿美元成长到 2034 年的 112.1 亿美元，2026 年至 2034 年的复合年增长率为 10.03%。

受心血管疾病发病率上升和对先进心臟衰竭治疗方法需求不断增长的推动，心臟泵装置市场预计将显着增长。心臟帮浦装置，包括心室辅助装置（VAD）和人工心臟，对于需要机械辅助以维持充足血液循环的严重心臟病患者至关重要。随着人们对心臟病的认识不断提高，以及对有效治疗方法的需求日益增长，对心臟泵装置的需求也将随之增加，预计该市场将稳步扩张。

此外，心臟泵技术的进步正在推动市场创新。更小巧、更有效率、更俱生物相容性的设备的研发，正在提升心臟泵的性能和实用性。这些创新不仅改善了患者的治疗效果，还有助于降低设备植入和长期使用相关的风险。随着对心臟泵设备新材料、新设计和新应用领域的研究不断深入，在改善患者照护和生活品质的推动下，市场预计将进一步扩张。

此外，对个人化医疗和以患者为中心的治疗方案的日益重视正在改变心臟泵设备的模式。随着医疗服务提供者越来越认识到根据每位患者的个别需求量身定制治疗方案的重要性，能够适应不同程度心臟衰竭和患者特征的心臟泵设备的需求预计将会增加。这一趋势在临床试验和新型治疗方法的研发中尤其重要，因为个人化治疗方案可以改善治疗效果。随着心臟泵设备市场的不断发展，技术进步、对个人化医疗的关注以及对有效心血管解决方案的需求将共同发挥关键作用，塑造其未来的发展轨迹。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球心臟帮浦设备市场：依产品类型划分

• 市场分析、洞察与预测
• 种植类型
• 体外安装类型

第五章：全球心臟帮浦装置市场：依治疗方法划分

• 市场分析、洞察与预测
• 等待移植
• 不适合移植患者的永久性治疗
• 手术后等待身体恢復期间的临时支撑。
• 治疗计画待定

第六章 全球心臟帮浦设备市场：依最终用户划分

• 市场分析、洞察与预测
• 医院
• 门诊手术中心
• 专科诊所

第七章 全球心臟帮浦设备市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第八章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第九章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Abbott Laboratories
  • Medtronic Plc
  • Abiomed Inc
  • Boston Scientific Corporation
  • Getinge AB
  • Terumo Corporation
  • LivaNova PLC
  • SynCardia Systems LLC
  • Jarvik Heart Inc
  • Fresenius Medical Care AG & Co. KGaA
  • Berlin Heart GmbH
  • Carmat SA
  • CorWave SA
  • Evaheart Inc
  • HeartWare International Inc

The Heart Pump Device Market size is expected to reach USD 11.21 Billion in 2034 from USD 4.74 Billion (2025) growing at a CAGR of 10.03% during 2026-2034.

The heart pump device market is poised for significant growth, driven by the increasing prevalence of cardiovascular diseases and the rising demand for advanced heart failure treatments. Heart pump devices, including ventricular assist devices (VADs) and total artificial hearts, are essential for supporting patients with severe heart conditions who require mechanical assistance to maintain adequate blood circulation. As awareness of heart disease grows and the need for effective treatment options increases, the demand for heart pump devices is expected to rise, positioning this market for robust expansion.

Moreover, advancements in heart pump technology are propelling innovation within the market. The development of smaller, more efficient, and biocompatible devices is enhancing the performance and usability of heart pumps. These innovations not only improve patient outcomes but also reduce the risks associated with device implantation and long-term use. As research continues to explore new materials, designs, and applications for heart pump devices, the market is likely to expand further, driven by the promise of improved patient care and quality of life.

Additionally, the growing emphasis on personalized medicine and patient-centered approaches is shaping the heart pump device landscape. As healthcare providers increasingly recognize the importance of tailoring treatments to individual patient needs, the demand for heart pump devices that can accommodate varying levels of heart failure and patient characteristics is likely to increase. This trend is particularly relevant in the context of clinical trials and the development of new therapies, where personalized approaches can enhance treatment efficacy. As the heart pump device market continues to evolve, the combination of technological advancements, a focus on personalized care, and the need for effective cardiovascular solutions will play a crucial role in shaping its future trajectory.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Implantable Heart Pump Devices
• Extracorporeal Heart Pump Devices

By Therapy

• Bridge-To-Transplant
• Destination Therapy
• Bridge-To-Recovery
• Bridge-To-Candidacy

By End-User

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics

COMPANIES PROFILED

• Abbott Laboratories, Medtronic plc, Abiomed Inc, Boston Scientific Corporation, Getinge AB, Terumo Corporation, LivaNova PLC, SynCardia Systems LLC, Jarvik Heart Inc, Fresenius Medical Care AG Co KGaA, Berlin Heart GmbH, Carmat SA, CorWave SA, Evaheart Inc, HeartWare International Inc

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL HEART PUMP DEVICE MARKET: BY PRODUCT TYPE 2022-2034 (USD MN and K Units)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Implantable Heart Pump Devices Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
• 4.3. Extracorporeal Heart Pump Devices Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)

Chapter 5. GLOBAL HEART PUMP DEVICE MARKET: BY THERAPY 2022-2034 (USD MN and K Units)

• 5.1. Market Analysis, Insights and Forecast Therapy
• 5.2. Bridge-To-Transplant Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
• 5.3. Destination Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
• 5.4. Bridge-To-Recovery Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
• 5.5. Bridge-To-Candidacy Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)

Chapter 6. GLOBAL HEART PUMP DEVICE MARKET: BY END-USER 2022-2034 (USD MN and K Units)

• 6.1. Market Analysis, Insights and Forecast End-user
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
• 6.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
• 6.4. Specialty Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)

Chapter 7. GLOBAL HEART PUMP DEVICE MARKET: BY REGION 2022-2034(USD MN and K Units)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and K Units)
  • 7.2.1 By Product Type
  • 7.2.2 By Therapy
  • 7.2.3 By End-user
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN and K Units)
  • 7.3.1 By Product Type
  • 7.3.2 By Therapy
  • 7.3.3 By End-user
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN and K Units)
  • 7.4.1 By Product Type
  • 7.4.2 By Therapy
  • 7.4.3 By End-user
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and K Units)
  • 7.5.1 By Product Type
  • 7.5.2 By Therapy
  • 7.5.3 By End-user
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN and K Units)
  • 7.6.1 By Product Type
  • 7.6.2 By Therapy
  • 7.6.3 By End-user
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL HEART PUMP DEVICE INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Abbott Laboratories
  • 9.2.2 Medtronic Plc
  • 9.2.3 Abiomed Inc
  • 9.2.4 Boston Scientific Corporation
  • 9.2.5 Getinge AB
  • 9.2.6 Terumo Corporation
  • 9.2.7 LivaNova PLC
  • 9.2.8 SynCardia Systems LLC
  • 9.2.9 Jarvik Heart Inc
  • 9.2.10 Fresenius Medical Care AG & Co. KGaA
  • 9.2.11 Berlin Heart GmbH
  • 9.2.12 Carmat SA
  • 9.2.13 CorWave SA
  • 9.2.14 Evaheart Inc
  • 9.2.15 HeartWare International Inc